Two Sigma Investments, LP Theravance Biopharma, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $410,545 - $491,268	49,523 New	49,523 $419,000
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $334,096 - $443,904	38,939 New	38,939 $437,000
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $3.04 Million - $3.56 Million	-298,809 Reduced 83.73%	58,058 $600,000
Q1 2023 May 15, 2023	SELL	$9.87 - $11.44 $5.98 Million - $6.93 Million	-605,959 Reduced 62.94%	356,867 $3.87 Million
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $2.99 Million - $3.51 Million	309,956 Added 47.48%	962,826 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $5.48 Million - $6.67 Million	652,870 New	652,870 $6.62 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $1.26 Million - $1.54 Million	-149,240 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $951,069 - $1.48 Million	114,174 Added 325.6%	149,240 $1.43 Million
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $260,189 - $387,479	35,066 New	35,066 $387,000
Q2 2021 Aug 16, 2021	SELL	$14.52 - $22.46 $594,768 - $920,006	-40,962 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $678,740 - $863,478	40,962 New	40,962 $836,000
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $588,437 - $796,703	-39,519 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $1.96 Million - $2.98 Million	-132,531 Reduced 77.03%	39,519 $584,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $3.55 Million - $5.28 Million	172,050 New	172,050 $3.61 Million
Q4 2018 Feb 14, 2019	SELL	$22.52 - $35.07 $352,573 - $549,055	-15,656 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$22.83 - $32.67 $357,426 - $511,481	15,656 New	15,656 $511,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.2 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.1 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account